Remsima for IBD in New Injection Form Shows Safety and Efficacy in Trial

Remsima, an approved biosimilar of Remicade for active Crohn’s and ulcerative colitis, was safe and effective given as a potential under-the-skin injection.

Related Keywords

Vienna ,Wien ,Austria ,Israel ,Shomron Ben Horin ,Chaim Sheba Medical Center ,Colitis Organisation ,Drug Administration ,Janssen Immunology ,Disease Activity Index ,European Crohn ,